295 related articles for article (PubMed ID: 27200049)
1. In Search of Enzymes with a Role in 3', 5'-Cyclic Guanosine Monophosphate Metabolism in Plants.
Gross I; Durner J
Front Plant Sci; 2016; 7():576. PubMed ID: 27200049
[TBL] [Abstract][Full Text] [Related]
2. Cyclic guanosine monophosphate in the regulation of the cell function.
Zbrojkiewicz M; Śliwiński L
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1276-1285. PubMed ID: 28026830
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide on the cyclic guanosine monophosphate (cGMP) pathway during meiosis resumption in bovine oocytes.
Schwarz KR; Pires PR; Mesquita LG; Chiaratti MR; Leal CL
Theriogenology; 2014 Mar; 81(4):556-64. PubMed ID: 24331454
[TBL] [Abstract][Full Text] [Related]
4. The cGMP system: components and function.
Hofmann F
Biol Chem; 2020 Mar; 401(4):447-469. PubMed ID: 31747372
[TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel Arabidopsis thaliana nitric oxide-binding molecule with guanylate cyclase activity in vitro.
Mulaudzi T; Ludidi N; Ruzvidzo O; Morse M; Hendricks N; Iwuoha E; Gehring C
FEBS Lett; 2011 Sep; 585(17):2693-7. PubMed ID: 21820435
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
8. The Arabidopsis thaliana proteome harbors undiscovered multi-domain molecules with functional guanylyl cyclase catalytic centers.
Wong A; Gehring C
Cell Commun Signal; 2013 Jul; 11():48. PubMed ID: 23835195
[TBL] [Abstract][Full Text] [Related]
9. Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide.
Sawa T; Ihara H; Ida T; Fujii S; Nishida M; Akaike T
Nitric Oxide; 2013 Nov; 34():10-8. PubMed ID: 23632125
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside.
Jackson EB; Mukhopadhyay S; Tulis DA
Curr Vasc Pharmacol; 2007 Jan; 5(1):1-14. PubMed ID: 17266609
[TBL] [Abstract][Full Text] [Related]
11. A cell-based nitric oxide reporter assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway.
Wunder F; Buehler G; Hüser J; Mundt S; Bechem M; Kalthof B
Anal Biochem; 2007 Apr; 363(2):219-27. PubMed ID: 17336915
[TBL] [Abstract][Full Text] [Related]
12. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
13. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
von Bülow V; Rink L; Haase H
J Immunol; 2005 Oct; 175(7):4697-705. PubMed ID: 16177117
[TBL] [Abstract][Full Text] [Related]
14. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
DeRubertis FR; Craven P
Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
16. Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
Xiao S; Li Q; Hu L; Yu Z; Yang J; Chang Q; Chen Z; Hu G
Mini Rev Med Chem; 2019; 19(18):1544-1557. PubMed ID: 31362687
[TBL] [Abstract][Full Text] [Related]
17. Structure and regulation of soluble guanylate cyclase.
Derbyshire ER; Marletta MA
Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
[TBL] [Abstract][Full Text] [Related]
18. Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors.
Blute TA; Velasco P; Eldred WD
Vis Neurosci; 1998; 15(3):485-98. PubMed ID: 9685201
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
Ghalayini IF
Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
[TBL] [Abstract][Full Text] [Related]
20. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]